Publications by authors named "Thomas Plenge"

Claim this Profile
C
Catalytic Inhibition of KAT6/KAT7 Enhances the Efficacy and Overcomes Primary and Acquired Resistance to Menin Inhibitors in MLL Leukemia.
Shellaina J V Gordon, Florian Perner, Laura MacPherson, Katie A Fennell, Daniela V Wenge, Thomas Plenge

Cancer Discov· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The histone-methyltransferase DOT1L cooperates with LSD1 to control cell division in blast-phase MPN.
Karl Kapahnke, Thomas Plenge, Tabea Klaus, Manoj K Gupta, Disha Anand

Leukemia· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML.
Viktor Fetsch, Lennard Frederik Schwöbel, Ezgi Ozyerli-Goknar, Anna-Verena Stell, Marco Punta, Thomas Plenge

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XPO1-dependency of DEK::NUP214 leukemia.
Fiorella Charles Cano, Arnold Kloos, Rucha Y Hebalkar, Thomas Plenge, Robert Geffers

Leukemia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levetiracetam for the treatment of alcohol withdrawal syndrome: a multicenter, prospective, randomized, placebo-controlled trial.
Christoph Richter, Axel Hinzpeter, Folkhard Schmidt, Thorsten Kienast, Ulrich W Preuss, Thomas Plenge

J Clin Psychopharmacol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The starting phase of a psychiatric unit--a statistical study].
Thomas Plenge, Marc Eilers, Michael Hettich, Rainer Tölle

Psychiatr Prax· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis